{"id":31627,"date":"2026-07-07T04:00:00","date_gmt":"2026-07-07T02:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=6af61897b8953cdd60a4c5c515a7c76a"},"modified":"2026-07-07T04:00:00","modified_gmt":"2026-07-07T02:00:00","slug":"real-chemistry-announces-new-asia-pacific-hub-with-acquisition-of-spurwing-communications-in-singapore","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=31627","title":{"rendered":"Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore"},"content":{"rendered":"<p class=\"bwalignc\">\n<i>Expanded footprint advances the company\u2019s global strategy in key growth region for healthcare and pharma brands<\/i><\/p><p>SINGAPORE--(BUSINESS WIRE)--Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company\u2019s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry\u2019s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support \u2014 ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260706477680\/en\/2838954\/5\/RealChemistry_Logo_Black_%282%29.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260706477680\/en\/2838954\/22\/RealChemistry_Logo_Black_%282%29.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260706477680\/en\/2838954\/5\/RealChemistry_Logo_Black_%282%29.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260706477680\/en\/2838954\/21\/RealChemistry_Logo_Black_%282%29.jpg\" \/><\/a><p>\n\u201cAPAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,\u201d said Kath Harrison, Group President, International Growth at Real Chemistry. \u201cBy bringing Spurwing into Real Chemistry, we\u2019re expanding our presence in the region and deepening our ability to help clients drive measurable impact by delivering more connected, data-driven and culturally relevant engagement across these key markets.\u201d<\/p><p>\nFounded in Singapore, Spurwing Communications is a leading agency with an established track record advising pharmaceutical and healthcare organizations \u2014 as well as clients across a broader range of industries \u2014 throughout APAC. The company is known for high-impact strategic counsel across integrated communications, medical affairs and its nuanced understanding of the region\u2019s diverse and evolving market environments.<\/p><p>\nEmma Thompson, Founder and Chief Executive Officer (CEO) of Spurwing Communications, will continue to lead the business as President, APAC Growth, reporting to Harrison. \u201cJoining Real Chemistry allows us to broaden what we can offer clients, while staying grounded in the strong regional expertise and senior counsel for which our clients value us,\u201d said Thompson. \u201cI\u2019m extremely proud of what we have achieved as a team and excited for the next phase of our growth as part of Real Chemistry. We will continue to support our existing clients while expanding our APAC presence and adding capabilities \u2014 including analytics and AI \u2014 to enhance our connected, comprehensive regional offerings.\u201d<\/p><p>\n\u201cReal Chemistry\u2019s acquisition of Spurwing Communications is an important step in our global growth strategy,\u201d said Shankar Narayanan, CEO of Real Chemistry. \u201cWe\u2019re continuing to invest in the capabilities and regions that matter most to our clients as they navigate growing global commercialization challenges. Strengthening our presence in APAC allows us to better support clients across the full lifecycle \u2014 from strategy through engagement \u2014 in one of the most dynamic healthcare markets in the world.\u201d<\/p><p>\nAdditional hires and market expansion plans are expected to be announced over the coming months, as Real Chemistry continues to scale its regional hub model and affiliate network across key international markets.<\/p><p>\n<b>About Real Chemistry: 25 Years of Future-Focused Healthcare\n<br\/><\/b>Celebrating its 25th anniversary this year, Real Chemistry is a tier-one commercialization partner to the world\u2019s most innovative life sciences and healthcare companies. As a leading provider of AI-powered audience analytics and insights, Real Chemistry helps the healthcare industry better understand, reach and engage critical audiences to improve the healthcare experience for all. Anchored by a culture of innovation and creativity, Real Chemistry\u2019s 2,400+ global experts across life sciences, marketing communications and technology are singularly focused on navigating the complexities of bringing scientific advances to market \u2014 and to the people who need them most. Real Chemistry\u2019s brand portfolio includes 21GRAMS, a highly awarded creative agency, and starpower, a celebrity and influencer practice.<\/p><p>\nToday, Real Chemistry operates through offices across North America, Europe, the Middle East and Asia Pacific, complemented by a strategic partner network in Latin America and Africa \u2014 enabling the company to support clients wherever they operate.<\/p><p>\nLearn more at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.realchemistry.com&amp;esheet=54565566&amp;newsitemid=20260706477680&amp;lan=en-US&amp;anchor=www.realchemistry.com&amp;index=1&amp;md5=da534d5ef1ca801f866bed9d1c351479\" rel=\"nofollow\" shape=\"rect\">www.realchemistry.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Media:<\/b><br\/><a  href=\"mailto:media@realchemistry.com\" rel=\"nofollow\" shape=\"rect\">media@realchemistry.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Expanded footprint advances the company\u2019s global strategy in key growth region for healthcare and pharma brandsSINGAPORE&#8211;(BUSINESS WIRE)&#8211;Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquis&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-31627","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/31627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31627"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/31627\/revisions"}],"predecessor-version":[{"id":31628,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/31627\/revisions\/31628"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}